Skip to main content

Table 2 The role of SASP in tumor microenvironment

From: Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications

 

Cancer type

Senescent cell

Senescence inducer

Major roles of SASP

SASP factors

Protumorigenic SASP

hepatocyte

hepatocyte

OIS (N-Ras)

(1) myeloid cell recruitment; (2) MDSC differentiation

CCL2

hepatocyte

hepatic stellate cell

HFD

antitumor immunity of CD8+ T cells impairment

PGE2

lymphocyte

lymphocyte

TIS (doxorubicin)

stemness induction

not reported

mammary epithelial cell

mammary epithelial cell

TIS (doxorubicin)

mitogenic support

Eotaxin, CXCL5, Rantes

mammary epithelial cell

fibroblast

DNA damage (bleomycin)

cancer invasion promotion

MMPs

mammary epithelial cell

mammary epithelial cell

OIS (HER2)

cancer metastasis promotion

not reported

melanocyte

fibroblast

TIS (CDK4/6 inhibitor)

myeloid cell recruitment

not reported

mesothelial cell

mesothelial cell

TIS (pemetrexed)

(1) EMT induction; (2) chemoresistance

not reported

prostate epithelial cell

prostate epithelial cell

TIS (PTEN loss)

myeloid cell recruitment

CXCL1, CXCL2

prostate epithelial cell

prostate epithelial cell

TIS (PTEN loss)

MDSC recruitment

not reported

thyroid follicular cell

thyroid follicular cell

OIS (BRAF)

anoikis resistance

CXCL12

Antitumorigenic SASP

hepatocyte

hepatocyte

OIS (N-Ras)

immune-related senescent cell clearance

IL-1α

lymphocyte

lymphocyte

TIS (cyclophosphamide)

cellular senescence reinforcement

not reported

melanocyte

melanocyte

TIS (AURKA or CDK4/6 inhibitor)

lymphocyte recruitment

CCL5

melanocyte

melanocyte

TIS (Aurora inhibitor)

cellular senescence reinforcement

not reported

osteoblast

osteoblast

TIS (radiotherapy)

NKT cell recruitment

IL-6

pancreatic ductal cell

pancreatic ductal cell

TIS (MEK and CDK4/6 inhibitors)

(1) vascularization promotion (2) drug delivery improvement (3) endothelial cell activation (4) CD8+ T-cell accumulation

VEGF, CCL5, CXCL1, IL-6

hepatocyte

hepatocyte

OIS (N-Ras)

(1) myeloid cell recruitment (2) macrophage differentiation

CCL2

  1. SASP senescence-associated secretory phenotype, OIS oncogene-induced senescence, HFD high-fat diet, TIS therapy-induced senescence, EMT epithelial–mesenchymal transition, MDSC myeloid-derived suppressor cells, NKT natural killer T cell (Mainly from https://doi.org/10.1002/1878-0261.13268)